Cancer remains a leading global cause of death, challenging researchers to find effective treatments. Immunotherapy harnesses the body's immune response, aiming to overcome cancer's ability to evade detection.

Cancer cells often develop clever tactics to hide from the immune system. By altering their surface markers, they become invisible to T cells, which are essential for immune responses.

Scientists have revealed DNA-PK inhibitors as a promising tool to unveil cancer cells. By blocking the DNA-PK protein, these inhibitors enhance cancer cell visibility, enabling T cells to recognize and attack effectively.

Researchers are pioneering a method to transform cancer cells into antigen-presenting cells (APCs).

Transforming cancer cells into APCs provides a unique opportunity for creating personalized cancer vaccines.

These breakthroughs indicate a path to overcome cancer's resistance mechanisms.

The future of cancer treatment looks promising with these innovative methods.